Login / Signup
Beyond the commonly mentioned limitations of the Journal Impact Factor, we discuss the obsolete principle of selecting journals to create a fake-representative sample of 'journals that matter' and the opacity around the calculation and listing of Impact Factors. We use the example of Pharmacy Practice: in 2015 for illustration. We hypothesize that a business-oriented system of measuring the science and quality of scholarly journals may not be the best option to avoid biases and conflicts of interest.
Keyphrases